Anti-vascular endothelial growth factor in neovascular age-related macular degeneration - a systematic review of the impact of anti-VEGF on patient outcomes and healthcare systems

Finger, Robert; Daien, Vincent; Eldem, Bora; Talks, James; Korobelnik, Jean-Francois; Mitchell, Paul; Sakamoto, Taiji; Wong, Tien; Pantiri, Krystallia; Carrasco, Joao

doi:10.1186/s12886-020-01554-2

Anti-vascular endothelial growth factor in neovascular age-related macular degeneration - a systematic review of the impact of anti-VEGF on patient outcomes and healthcare systems

Finger R. P., Daien V., Eldem B. M., Talks J. S., Korobelnik J., Mitchell P., ...Daha Fazla

BMC OPHTHALMOLOGY, cilt.20, sa.1, 2020 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Derleme
Cilt numarası: 20 Sayı: 1
Basım Tarihi: 2020
Doi Numarası: 10.1186/s12886-020-01554-2
Dergi Adı: BMC OPHTHALMOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE, Directory of Open Access Journals
Hacettepe Üniversitesi Adresli: Evet

Özet

Background: Systematically review the evidence describing the impact of anti-vascular endothelial growth factor (anti-VEGF) therapy on neovascular age-related macular degeneration (nAMD) patient outcomes and healthcare resource utilization.